Genotypic resistance testing of HCV – is there a clinical need?

Persistent infections with the hepatitis C virus (HCV) pose a profound global public health burden. In the past 5 years treatment of chronic hepatitis C has dramatically changed. Novel direct-acting antivirals (DAAs) specifically inhibiting viral enzymes or factors that are essential for the viral r...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Andreas, Kaiser, Rolf, Bartenschlager, Ralf, Timm, Jörg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301723/
https://www.ncbi.nlm.nih.gov/pubmed/30671319
http://dx.doi.org/10.3205/id000023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6301723/
https://www.ncbi.nlm.nih.gov/pubmed/30671319
http://dx.doi.org/10.3205/id000023

Ejemplares similares